The Icahn School of Medicine at Mount Sinai and The Chemotherapy Foundation
Last Modified: April 10, 2014
Dates: November 5-7, 2014
Location: The Marriott Marquis Hotel, NYC
Sponsoring Group: The Icahn School of Medicine at Mount Sinai and The Chemotherapy Foundation
Web Page URL: chemotherapyfoundationsymposium.org
Topics Covered: Hematology, GI Sessions, Pediatric Oncology, GYN, Head and Neck, CNS, Breast Cancer,Prostate, Renal, Bladder, Lung Cancer, Personalized Therapy, Melanoma, Patient Care
Objectives: Founded in 1972 by Ezra Greenspan, we continue to bring the groundbreaking advances spearheading progress in cancer therapeutics to community and academic practitioners. Leading oncologist and hematologist investigators will report on new regimens, clinical trials and emerging therapeutic advances in common cancer types.
Who Should Attend: Physicians and other Cancer Providers (Nurses, PAs, NPs, House Staff, Fellows, Pharmacists, Industry)
Agenda: 2014 Agenda in progress. Updates can be found at: www.chemotherapyfoundationsymposium.org/CMS/programs
Registration Information: Register online at www.chemotherapyfoundationsymposium.org/CMS/
Fees: See chemotherapyfoundationsymposium.org
Continuing Education: Yes
Miscellany: This is a CME accredited educational activity jointly presented by the Icahn School of Medicine at Mount Sinai and the Chemotherapy Foundation, a non-profit organization supporting cancer research, in collaboration with The Tisch Cancer Institute.
Jan 20, 2011 - The combination of chemotherapy with intensity-modulated radiation therapy is equally as effective for the treatment of anal cancer after two years as the combination of chemotherapy and conventionally delivered radiation therapy, as well as less toxic, according to a study presented at the American Society of Clinical Oncology's annual Gastrointestinal Cancers Symposium, held from Jan. 20 to 22 in San Francisco.